Cullinan Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,906
Closed -$202K 186
2018
Q1
$202K Hold
1,906
0.02% 180
2017
Q4
$223K Buy
1,906
+52
+3% +$5.88K 0.02% 179
2017
Q3
$211K Hold
1,854
0.02% 187
2017
Q2
$231K Sell
1,854
-185
-9% -$21.9K 0.02% 192
2017
Q1
$242K Sell
2,039
-25,853
-93% -$2.93M 0.02% 192
2016
Q4
$2.79M Buy
27,892
+1,854
+7% +$199K 0.24% 105
2016
Q3
$3.29M Buy
26,038
+103
+0.4% +$12.7K 0.28% 93
2016
Q2
$3.03M Sell
25,935
-7,674
-23% -$868K 0.25% 95
2016
Q1
$3.48M Sell
33,609
-103
-0.3% -$9.96K 0.3% 89
2015
Q4
$3.36M Sell
33,712
-5,253
-13% -$514K 0.29% 84
2015
Q3
$3.55M Buy
38,965
+1,545
+4% +$155K 0.32% 71
2015
Q2
$3.97M Buy
37,420
+196
+0.5% +$21.7K 0.33% 73
2015
Q1
$4.25M Buy
37,224
+3,708
+11% +$423K 0.33% 66
2014
Q4
$3.69M Buy
33,516
+4,151
+14% +$438K 0.39% 44
2014
Q3
$2.87M Buy
29,365
+2,276
+8% +$224K 0.33% 49
2014
Q2
$1.97M Sell
27,089
-6,592
-20% -$643K 0.32% 44
2014
Q1
$3.09M Sell
33,681
-1,030
-3% -$94.9K 0.35% 42
2013
Q4
$3.14M Buy
34,711
+2,513
+8% +$217K 0.36% 43
2013
Q3
$2.57M Buy
32,198
+4,388
+16% +$345K 0.34% 45
2013
Q2
$2.02M Buy
+27,810
New +$2.08M 0.27% 50

Other funds holding ZBH

Cullinan Associates's ZBH Position: Q2 2018 in Review

Cullinan Associates sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 1,906 shares — an estimated $202K sold.

Cullinan Associates first reported a position in ZBH in Q2 2013 and held it in 20 quarters. The position peaked at $4.25M in Q1 2015. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Cullinan Associates reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
  • Cullinan Associates sold 1,906 Zimmer Biomet shares in Q2 2018, an estimated $202K.
  • Cullinan Associates first reported a position in Zimmer Biomet in Q2 2013 and held it in 20 quarters.
  • Cullinan Associates's Zimmer Biomet position peaked at $4.25M in Q1 2015.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Cullinan Associates's 13F filing for Q2 2018, filed 9 Jul 2018.